🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Has anyone dealt with okay who else cannot stop burping? Page 3

Has anyone dealt with okay who else cannot stop burping?

LeilaHI Thu, Feb 22, 2024 at 7:58 AM 15 replies 2,173 viewsPage 3 of 3
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Feb 23, 2024 at 3:17 AM#11
PharmHunterJen said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.

49 22steve_okc, dave_SLC, FDA_TrackerJim and 46 others
Reply Quote Save Share Report
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Feb 23, 2024 at 12:34 PM#12
RetaRick_CA said:
The dose-response is real but shallow at the top.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Printing the relevant bit and taking it with me.

50 23BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 47 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Feb 23, 2024 at 9:51 PM#13
PharmHunterJen said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

1 24Dr.ReproEndo
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Feb 24, 2024 at 7:08 AM#14

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Feb 24, 2024 at 9:08 AM
2 0KarenAZ_mom, zoe_NC
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 24, 2024 at 4:25 PM#15

Moderator note: a couple of off-topic posts removed. Carry on.

Last edited: Feb 24, 2024 at 8:25 PM
3 1PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register